UBC Home Page -
UBC Home Page -
UBC Home Page UBC Home Page -
-
-
News Events Directories Search UBC myUBC Login
-
- -
UBC Public Affairs
News
UBC Reports
Media Releases
Past Media Releases
Services for Media
Services for the Community
Services for UBC Faculty & Staff
Find UBC Experts
Search Site
-

Media Release | Dec. 15, 1997

UBC researcher wins top Canadian research prize

Terry Snutch, a professor in UBC's Biotechnology Lab, has won the Steacie Prize, Canada's most prestigious award for young scientists and engineers.

The $10,000 award comes in recognition of Snutch's outstanding research into the function of calcium channels in the body. Snutch is the seventh UBC researcher to win the prize since its inception in 1964, and the first from UBC in the life sciences field.

Snutch and his research team investigate how calcium gets in and out of the brain's 100 billion nerve cells, or neurons, and triggers electrical and chemical signals enroute. Calcium plays an important role as a messenger between neurons that control skeletal, heart and smooth muscle contraction, hormone secretion and all electrical signaling in the central nervous system. However, too much calcium entering a cell, through so-called calcium channels, can be toxic.

The prize is awarded annually to a person of up to age 40 by the E.W.R. Steacie Memorial Fund, a private foundation dedicated to the advancement of science and engineering in Canada. It is named in memory of E.W.R. Steacie, a physical chemist and former president of the National Research Council (NRC) of Canada, who is recognized for his strong support for the development of science in Canada.

"Terry Snutch's research program is generating results that have already had a major impact on his field and hold great promise for the treatment of many serious human ailments," said Bernie Bressler, UBC's vice-president, Research.

Snutch's research during the last eight years has led to a number of major breakthroughs. He has identified and cloned five genes encoding channels that regulate calcium entry into brain cells. Some of these genes are also turned on in the heart.

Snutch's research holds promise for the creation of novel drugs to treat cardiovascular disorders including hyertension, angina and certain arrhythmias. Migraine headaches and some forms of epilepsy are other disorders also shown to involve calcium entry into cells.

Processes developed in his lab have enabled scientists to study channels outside the brain and to use this information to design and screen for drugs that can either block or excite certain channels by themselves without risk of affecting other channels.

One of the channels that Snutch cloned is blocked by a toxin that a Micronesian cone snail uses to paralyse its prey. The toxin also blocks channels involved in strokes and pain transmission. A drug company in the U.S. has taken this information and is developing a pain reliever reported to be a thousand times more sensitive than morphine.

-30-

- - -

Contact

Prof. Terry Snutch
UBC Biotechnology Laboratory
Tel: 604.822.6968

Dr. Peter Hackett
E.W.R. Steacie Memorial Fund
Tel: 613.993.1212

Stephen Forgacs
UBC Public Affairs
Tel: 604.822.2048

-

Last reviewed 22-Sep-2006

to top | UBC.ca » UBC Public Affairs

UBC Public Affairs
310 - 6251 Cecil Green Park Road, Vancouver, BC Canada V6T 1Z1
tel 604.822.3131 | fax 604.822.2684 | e-mail public.affairs@ubc.ca

© Copyright The University of British Columbia, all rights reserved.